Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Michael Holte Heggeness

Michael Holte Heggeness

University of Kansas School of Medicine-Wichita, USA USA. USA

Brian M Mehling

Brian M Mehling

Blue Horizon International LLC, USA USA USA

Y James Kang

Y James Kang

Sichuan University, China China China

Hazem Barmada

Hazem Barmada

Mississippi Stem cell Treatment Center, USA USA USA

Verdon Taylor

Verdon Taylor

University of Basel, Switzerland Switzerland Switzerland

Jane Lebkowski

Jane Lebkowski

Asterias Biotherapeutics, USA USA USA

Stem Cell Convention-2017

Sessions/Tracks

Conferenceseries LLC invites all the members of ecological family, from all over the world to join and share research at the “10th World Congress on Stem Cell and Biobanking” during 23th & 24th October, 2017 at Osaka, Japan, which includes prompt keynote presentations, plenary talks, oral talks, poster presentations and exhibitions.
Theme: “Accelerating the Innovative Research &Technology in Stem Cell & Biobanking
Stem Cell and Biobanking 2017 aims in proclaim knowledge and share new ideas amongst the professionals, industrialists and students from research area of Stem Cell and Biobanking to share their research experiences and indulge in interactive discussions at the event. This scientific gathering guarantees that offering the thoughts and ideas will enable and secure you the theme “Accelerating the Innovative Research &Technology in Stem Cell & Biobanking”. Biobanking is the latest trending technology in many fields. The current era fully rolled out with many new Stem cell and Biobanking technologies. In such case more research centres and Hospitals were newly introduced within market which obviously shows the market growth of stem cell and Biobanking techniques. While analyzing the revenue growth of stem cell research, it highly developed from $150 billion USD to $250 billion USD since from 2010-2015. And the annual growth percentage increases from 20-55 percentages.
 
 
Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. They are found in multicellular organisms. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cells—ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)—but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.
 
2nd World Congress on Molecular Genetics and Gene Therapy July 03-05, 2017 Thailand, Bangkok; 2ndInternational Conference on Antibodies July 14-15, 2016 Philadelphia, USA; 2nd International Conference on Innate Immunity July 21-22, 2016 Berlin, Germany; 2nd International Congress on Neuroimmunology  March 31-April 02, 2016 Atlanta, USA; International Conference on Cancer Immunology  July 28-30, 2016 Melbourne, Australia; 5th International Conference on Immunology October 24-26, 2016 Chicago, USA; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Mar 6–10 2016, Whistler, Canada; Systems Immunology: From Molecular Networks to Human Biology, Jan 10–14 2016, Big Sky, USA; Novel Immunotherapeutics Summit, Jan 25–26 2016, San Diego, USA; Stromal Cells in Immunity, Feb 7–11 2016, Keystone, USA; 26th European Congress of Clinical Microbiology, April 9–12 2016, Istanbul, Turkey
 
 
Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation. Although early research has focused on hematopoietic stem cells, stem cells have also been recognised in other sites. Research into solid tissue stem cells has not made the same progress as that on hematopoietic stem cells. This is due to the difficulty of reproducing the necessary and precise three dimensional arrangements and tight cell-cell and cell-extracellular matrix interactions that exist in solid organs. However, the ability of tissue stem cells to integrate into the tissue cytoarchitecture under the control of the host microenvironment and developmental cues makes them ideal for cell replacement therapy.
 
8th World Congress on Stem Cell Research March 20-22, 2017 Orlando, USAInternational Conference on Cancer Immunology  July 28-30, 2016 Melbourne, Australia; 5th International Conference on Immunology October 24-26, 2016 Chicago, USA; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Mar 6–10 2016, Whistler, Canada; Systems Immunology: From Molecular Networks to Human Biology, Jan 10–14 2016, Big Sky, USA; Novel Immunotherapeutics Summit, Jan 25–26 2016, San Diego, USA; Stromal Cells in Immunity, Feb 7–11 2016, Keystone, USA; 26th European Congress of Clinical Microbiology, April 9–12 2016, Istanbul, Turkey
 
 
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Research is underway to develop various sources for stem cells, and to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes, heart disease, and other conditions.
 
4th International Conference on Plant Genomics July 14-15, 2016 Brisbane, Australia; 8th World Congress on Stem Cell Research March 20-22, 2017 Orlando, USA; 7th Annual Conference on Stem Cell and Regenerative Medicine Aug 4-5, 2016, Manchester, UK; 2nd International Conference on Tissue preservation and Biobanking September 12-13, 2016 Philadelphia, USA, USA; World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; 12th Euro Biotechnology Congress November 7-9, 2016 Alicante, Spain; 2nd International Conference on Germplasm of Ornamentals, Aug 8-12, 2016, Atlanta, USA; 7thInternational conference on Crop Science, Aug 14–19 2016, Beijing, China; Plant Epigenetics: From Genotype to Phenotype, Feb 15–19 2016, Taos, USA; Germline Stem Cells Conference, June 19–21 2016, San Francisco, USA; Conference on Water Stress in Plants, 29 May – 3 June 2016, Ormont-Dessus, Switzerland
 
 
Epigenetics is the study of potentially heritable changes in gene expression (active versus inactive genes) that does not involve changes to the underlying DNA sequence — a change in phenotype without a change in genotype — which in turn affects how cells read the genes. Epigenetic change is a regular and natural occurrence but can also be influenced by several factors including age, the environment/lifestyle, and disease state. Epigenetic modifications can manifest as commonly as the manner in which cells terminally differentiate to end up as skin cells, liver cells, brain cells, etc. Or, epigenetic change can have more damaging effects that can result in diseases like cancer. At least three systems including DNA methylation, histone modification and non-coding RNA (ncRNA)-associated gene silencing are currently considered to initiate and sustain epigenetic change. New and ongoing research is continuously uncovering the role of epigenetics in a variety of human disorders and fatal diseases.
 
 
International Conference on Next Generation Sequencing July 21-22, 2016 Berlin, Germany; 5thInternational Conference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; 7thInternational Conference on Bioinformatics October 27-28, 2016 Chicago, USA; International Conference on Synthetic Biology September 28-30, 2015 Houston, USA; 4th International Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; 1st International Conference on Pharmaceutical Bioinformatics Jan 24–26 2016, Pattaya, Thailand; EMBL Conference: The Epitranscriptome, Apr 20–22 2016, Heidelberg, Germany; 2016 Whole-Cell Modeling Summer School, Apr 3–8 2016, Barcelona, Spain; 3rdInternational Molecular Pathological Epidemiology, May 12–13 2016, Boston, USA; 5th Drug Formulation Summit, Jan 25–27 2016, Philadelphia, USA
 
 
Self-renewal and proliferation of stem cell populations is controlled, in part, by induction of apoptosis. The number of stem cells is therefore a balance between those lost to differentiation / apoptosis and those gained through proliferation. Apoptosis of stem cells is believed to be a dynamic process which changes in response to environmental conditions. For example, the release of stem cell factor inhibits apoptosis following spinal cord injury, presumably in an attempt to promote tissue repair. Dysregulation of apoptosis in stem cells is believed to underlie some cancer pathologies, where apoptotic resistance results in uncontrolled growth (i.e. glioblastoma). Controlling apoptosis is also an important focus for studies of stem cell transplantation, where inhibition may increase the survival of grafted cells during replacement therapy. Harnessing the full therapeutic potential of stem cells will require full elucidation of the signal transduction cascades for proliferation, differentiation, and apoptosis.
 
 
7th International Conference on Bioinformatics October 27-28, 2016 Chicago, USA; International Conference on Synthetic Biology September 28-30, 2015 Houston, USA; 7th Annual Conference on Stem Cell and Regenerative Medicine Aug 4-5, 2016, Manchester, UK; 4th International Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; 1st International Conference on Pharmaceutical Bioinformatics Jan 24–26 2016, Pattaya, Thailand; EMBL Conference: The Epitranscriptome, Apr 20–22 2016, Heidelberg, Germany; 2016 Whole-Cell Modeling Summer School, Apr 3–8 2016, Barcelona, Spain; 3rd International Molecular Pathological Epidemiology, May 12–13 2016, Boston, USA; 5th Drug Formulation Summit, Jan 25–27 2016, Philadelphia, USA
 
 
Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs.
 
International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;; 3rd World Congress on Hepatitis and Liver Diseases    October 17-19, 2016 Dubai, UAE; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Tissue preservation and Biobanking  September12-13, 2016 Philadelphia USA; 26th European Congress of Clinical Microbiology, April 9–12 2016, Istanbul, Turkey;Conference on Cell Growth and Regeneration, Jan 10–14 2016, Breckenridge, USA ;
 
 
Biobanks play a crucial role in biomedical research. The wide array of bio specimens (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Biobanks catalog specimens using genetic and other traits, such as age, gender, blood type, and ethnicity. Some samples are also categorized according to environmental factors, such as whether the donor had been exposed to radiation, asbestos, or some other substance that can affect human genes.
 
 
8th World Congress on Stem Cell Research March 20-22, 2017 Orlando, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 7th Annual Conference on Stem Cell and Regenerative Medicine Aug 4-5, 2016, Manchester, UK; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Tissue preservation and Biobanking  September12-13, 2016 Philadelphia USA; Conference on Cardiac Development, Regeneration and Repair April 3 – 7, 2016 Snowbird, Utah, USA; Stem Cell Development May 22-26, 2016 Hillerød, Denmark; Conference on Hematopoietic Stem Cells, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency - March 22-24, 2016 Kyoto, Japan
 
 
Cancer stem cells are cells found in tumors that have the ability to propagate the tumor after its dissociation.  In some tumors, this property is expressed by a large fraction of the total tumor cells, meaning abundant cancer stem cells.  However, in many tumors the cancer stem cell fraction is small, mimicking the smaller fractions of stem cells in normal adult tissues.  This distribution of cancer stem cells has captured the imagination of cancer scientists.  There is speculation that cancer stem cells at low fractions in tumors may be responsible for cancer drug resistance, metastasis, and tumor recurrence.
Due to the widely-held importance of cancer stem cells in cancer development and treatment, there is considerable interest in identifying, quantifying, and investigating them.  However, because of the inherent heterogeneity of human tumor cellularity, the search for cancer stem cell specific biomarkers has been even more fraught with false positives than the search for specific biomarkers for normal tissue stem cells.
 
International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham, UK; World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 3rd International Conference on Genomics & Pharmacogenomics September 21-23, 2015 San Antonio, USA; European Conference on Genomics and Personalized Medicine April 25-27, 2016 Valencia, Spain; Genomics and Personalized Medicine, Feb 7–11 2016, Banff, Canada; Drug Discovery for Parasitic Diseases, Jan 24–28 2016, Tahoe City, USA; Heart Failure: Genetics, Genomics and Epigenetics, April 3–7 2016, Snowbird, USA; Understanding the Function of Human Genome Variation, May 31– June 4 2016, Uppsala, Sweden; 5th Drug Formulation Summit Jan25–27,2016,Philadelphia, USA
 
 
Regeneration means the regrowth of a damaged or missing organ part from the remaining tissue. As adults, humans can regenerate some organs, such as the liver. If part of the liver is lost by disease or injury, the liver grows back to its original size, though not its original shape. And our skin is constantly being renewed and repaired. Unfortunately many other human tissues don’t regenerate, and a goal in regenerative medicine is to find ways to kick-start tissue regeneration in the body, or to engineer replacement tissues.
 
4th Congress on Bacteriology and Infectious Diseases May 16-18, 2016 San Antonio, USA; 2nd World Congress on Applied Microbiology October 31-November 02, 2016 Istanbul, Turkey; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada; International Conference on Water Microbiology  July 18-20, 2016 Chicago, USA; 5th International Conference on Clinical Microbiology October 24-26, 2016 Rome, Italy; Axons: From Cell Biology to Pathology Conference, 24–27 January 2016, Santa Fe, USA; 26th European Congress of Clinical Microbiology April 9–12 2016, Istanbul, Turkey; Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 17–21 2016, Newport, USA; 7thEuropean Spores Conference, April 18–20 2016, Egham, UK; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, May 22–26 2016, Cape Town, South Africa
 
 
Fertility preservation is the effort to help cancer patients retain their fertility, or ability to procreate. Research into how cancer affects reproductive health and preservation options are growing, sparked in part by the increase in the survival rate of cancer patients. The main methods of fertility preservation are ovarian protection by GnRH agonists, cryopreservation of ovarian tissue, eggs or sperm, or of embryos after in vitro fertilization. The patient may also choose to use egg or sperm from a donor by third party reproduction rather than having biological children.
ART World Congress Symposium on Safe and Efficient IVF New York City, USA, Global Biobanking London, UK, The Biomarker Conference Orlando, Florida, USA, World Conference on Regenerative Medicine 2015 Leipzig, Germany, ESBB conference Johannesburg, South Africa, World Conference on Regenerative Medicine 2015 Leipzig Germany, Keystone Stem Cells and Regeneration in the Digestive Organs (X6) Keystone, Colorado, USA, Molecular and Cellular Basis of Growth and Regeneration (A3) Breckenridge, Colorado, USA, Keystone Cardiac Development, Regeneration and Repair (Z2) Snowbird, Utah, USA, Tissue Niches & Resident Stem Cells in Adult Epithelia Gordon Research Conference Hong Kong, China.
 
4th Congress on Bacteriology and Infectious Diseases May 16-18, 2016 San Antonio, USA; 2nd World Congress on Applied Microbiology October 31-November 02, 2016 Istanbul, Turkey; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada; International Conference on Water Microbiology  July 18-20, 2016 Chicago, USA; 5th International Conference on Clinical Microbiology October 24-26, 2016 Rome, Italy; Axons: From Cell Biology to Pathology Conference, 24–27 January 2016, Santa Fe, USA; 26th European Congress of Clinical Microbiology April 9–12 2016, Istanbul, Turkey; Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 17–21 2016, Newport, USA; 7th European Spores Conference, April 18–20 2016, Egham, UK; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, May 22–26 2016, Cape Town, South Africa
 
 
Ethical issues are commonly present in many aspects of Biobanking. The fact that Biobanks deal with human samples, invading an individual autonomy or limiting self-control, provokes a number of ethical issues. Who is actually competent to give informed consent and donate a sample? When individuals donate part of their body to a biobank, how is that human sample processed? Who is the owner of the sample? Who should decide how it should be used? Who has the right to know individual results of research? These and many more ethical dilemmas exist in the ethical framework of biobanks. With the recent rapid developments in Biobanking, all of these issues are magnified with plenty of further new questions continuously arising. Ethical framework has been the most controversial issue in the domain of biobanking. Thus, it is not surprising that there is a substantial literature focusing on ethical dilemmas in biobanking, such as informed consent, privacy, protection, and returning of results to participants. For many years, researchers at CRB have provided constructive advice on how to deal with ethical aspects of research using human tissue material and personal data. For more than 80 years tissue has been derived from human bodies, stored, distributed and used for therapeutic, educational, forensic and research purposes as part of healthcare routine in most western countries.
American Society for Bioethics and Humanities Houston, USA, Association of Bioethics World Congress Edinburgh, UK, Oxford Global Health and Bioethics International Conference Oxford shire, UK, CFP: Global Forum on Bioethics in Research Foundation Merieux, France, Hands On Biobanks 2016 conference Vienna, Austria, Global Biobanking London, UK, The Biomarker Conference Orlando, Florida – USA, ART World Congress Symposium on Safe and Efficient IVF New York City, United States, VIII International Postharvest Symposium: Enhancing Supply Chain and Consumer Benefits - Ethical and Technological Issues Cartagena, Murcia, Spain.
 
4th Congress on Bacteriology and Infectious Diseases May 16-18, 2016 San Antonio, USA; 2nd World Congress on Applied Microbiology October 31-November 02, 2016 Istanbul, Turkey; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada; International Conference on Water Microbiology  July 18-20, 2016 Chicago, USA; 5th International Conference on Clinical Microbiology October 24-26, 2016 Rome, Italy; Axons: From Cell Biology to Pathology Conference, 24–27 January 2016, Santa Fe, USA; 26th European Congress of Clinical Microbiology April 9–12 2016, Istanbul, Turkey; Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 17–21 2016, Newport, USA; 7th European Spores Conference, April 18–20 2016, Egham, UK; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, May 22–26 2016, Cape Town, South Africa
 
 
 
The global biopreservation market is expected to reach USD 3,731.03 Million by 2020 from USD 2,150.48 Million in 2015, growing at a CAGR of 11.65% between 2015 and 2020. Biopreservation is used to ensure the stability, quality and purity of biospecimens. With a CAGR of 23.7%, global market value for cryopreservation equipment used in stem cells industry is anticipated to worth US$2.2 billion by 2015. On a global scale, North America accounts for nearly 35% of the market and will likely witness a higher growth rate in the upcoming years, in comparison with Asia-Pacific. While US accounts for the highest share of the global market value on a country basis, India and China surpasses the US in terms of growth rate anticipated in the near future. As per our analysis, freezers represent more than half of the cryopreservation equipment market value while Cyropreservative reagents stand for a share of close to 20%. The global biopreservation market is poised for rapid growth between 2015 and 2020. The drivers include increasing healthcare expenditure, growing demand for preserving new-born’s stem cells, increasing R&D spending on research, and increasing adoption of regenerative medicine.
 
 
International Conference on Case Reports March 31-April 02, 2016 Valencia, Spain; 2nd International Meeting on Clinical Case Reports April 18-20, 2016 Dubai, UAE; 3rd Experts Meeting on Medical Case Reports May 09-11, 2016 New Orleans, Louisiana, USA; 12th Euro Biotechnology Congress November 7-9, 2016 Alicante, Spain; 2nd International Conference on Tissue preservation and Biobanking September 12-13, 2016 Philadelphia, USA; 11th World Conference Bioethics October 20-22, 2015 Naples, Italy; Annual Conference Health Law and Bioethics, May 6-7 2016 Cambridge, MA, USA; 27th Maclean Conference on Clinical Medical Ethics, Nov 13-14, 2015, Chicago, USA; CFP: Global Forum on Bioethics in Research, Nov 3-4, 2015, Annecy, France
 
 
Biorepositories provide a resource for researchers to increase understanding of complex diseases. Studies such as the Lung Genomics Research Consortium (LGRC), a two-year project launched in October 2009, are going a step further than standard biobanking practices and characterizing the samples with their molecular makeup. The molecular data can then be mined along with the clinical data. Led by National Jewish Health and funded by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health (NIH), the LGRC project consists of five institutions, including Dana-Farber Cancer Institute. Collaborators in the project work with samples banked at the Lung Tissue Research Consortium (LTRC), which houses tissue samples and blood from lung disease sufferers, primarily chronic obstructive pulmonary disease (COPD), along with a rich set of clinical data from patients
Immuno-Oncology London UK, Next-Generation Cancer Immunotherapies San Diego, USA, ESBB conference Johannesburg, South Africa, HandsOn Biobanks 2016 conference Vienna, Austria, American Society for Bioethics and Humanities Houston, USA, Craniofacial Morphogenesis & Tissue Regeneration Ventura, CA, USA, ISSCR Pluripotency: From basic science to therapeutic applications Kyoto, Japan, Craniofacial Morphogenesis & Tissue Regeneration Ventura, CA, USA, Phacilitate Cell & Gene Therapy World Washington D.C., USA, Notch Signaling in Development, Regeneration & Disease Gordon Research Conference Lewiston, ME, USA.
The biobanking market is poised for explosive growth if it can overcome the challenges of an adolescent industry. According to an August 2012 Infiniti Research report titled “Global Biobanking Market 2011-2015,” the biobanking market will increase 30 per cent from 2011 to 2015 to nearly $183 billion. Growth is being driven by an increase in population genetics studies, personalized medicine, and the use of genetic information in food safety, forensics, and disease surveillance.
 
4th Congress on Bacteriology and Infectious Diseases May 16-18, 2016 San Antonio, USA; 2nd World Congress on Applied Microbiology October 31-November 02, 2016 Istanbul, Turkey; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada; International Conference on Water Microbiology  July 18-20, 2016 Chicago, USA; 5th International Conference on Clinical Microbiology October 24-26, 2016 Rome, Italy; Axons: From Cell Biology to Pathology Conference, 24–27 January 2016, Santa Fe, USA; 26th European Congress of Clinical Microbiology April 9–12 2016, Istanbul, Turkey; Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 17–21 2016, Newport, USA; 7th European Spores Conference, April 18–20 2016, Egham, UK; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, May 22–26 2016, Cape Town, South Africa
 
 
 

 

About Conference

Hear, Explore and learn the latest research. Present before distinguished global audience. Collaborate, build partnerships and experience Japan. Join the global academic community.
 
Conferenceseries LLC invites all the participants across the globe to attend the 10th World Congress on Stem Cell and Biobanking October 23-24, 2017 Osaka, Japan. Stem Cell and Biobanking 2017 includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
 
Stem Cell and Biobanking 2017 aims in proclaim knowledge and share new ideas amongst the professionals, industrialists and students from research area of Stem Cell and Biobanking to share their research experiences and indulge in interactive discussions at the event. This scientific gathering guarantees that offering the thoughts and ideas will enable and secure you the theme “Accelerating Innovative Research &Technology in Stem Cell & Biobanking”. Stem Cell and Biobanking is the latest trending research in many fields especially in Organ cancer: breast, oral, head and neck Cancer Myeloid, lymphoid leukaemia’s, cancer treatments etc. The current era fully rolled out with many new advanced treatment technologies. In such case more Stem Cell research institutes were newly introduced within market which obviously shows the market growth of Stem Cell and Biobanking. While analysing the revenue growth of Stem Cell and Biobanking functions, it highly developed from $150 billion USD to $250 billion USD since from 2010-2015. And the annual growth percentage increases from 20-55 percentages. 
Importance and Scope:
Recently, there has been an increasing demand for quality and trained manpower in this evolving branch of biomedicine. As a result of this, stem cell research is emerging as a rage among the many career options available to people in associated fields. The current investment in stem cell research in India is more than 1000 crores. Most of the investment in stem cell research in India is in the government sector. So there are a lot of research opportunities on a national front in India. 
Why to attend?
With members from around the world focused on learning about Stem Cell and Biobanking, this is your single best opportunity to reach the largest assemblage of participants from the Stem cell research community. Conduct demonstrations, distribute information, acquire knowledge about current and trending Stem cell and Biobanking technologies, make a splash with a new research, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields are hallmarks of this conference.
        
Target Audience:
 Head of the Departments from the field of Biological sciences, Genetics, Regenerative medicine, Oncology…
Doctors from the fields of Oncology, surgery, organ transplantation, infertility, Clinical Trails
Stem cell and Biobanking Lab Directors/Associates
Stem cell researchers and academicians
Doctorates in Bio- Sciences
Professors and Students from Academia in the study of Stem cell and Biobanking research
Regenerative medicine Lab Directors/Associates
Professors of Life sciences  
 
Conference Highlights
 
·         Stem Cells Biology
·         Stem Cell technology
·         Stem Cell Therapy Research
·         Epigenetics
·         Stem cell apoptosis and signal transduction
·         Regenerative Medicine
·         Tissue Regeneration
·         Next Generation Bio-banking
·         Stem cell biomarkers
·         Cell & Organ Regeneration
·         Stem cell niches
·         Fertility Biobanks
·         Biobank Ethics
·         Market Analysis in Biobanking
·         Next Generation Biobanking 
 
Special Issues:
 
All accepted abstracts will be published in respective  International Journals.
 
Abstracts will be provided with Digital Object Identifier by Cross Ref.
 
 
 
 

 

Market Analysis

10th World Congress on Stem Cell and Biobanking

Success of the 9 Cell Science conferences series has given us the prospect to bring the gathering one more time for our 10th World Congress 2017 meet in October 23-24, 2017 Osaka, Japan. Since its commencement in 2011 cell science series has perceived around 750 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time. 

Stem Cell and Biobanking-2017 has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need. Stem cell and Biobanking-2017 will have an anticipated participation of 100-120 delegates from around the world to discuss the conference goal. 

History of Stem cells Research        

Stem cells have an interesting history; in the mid-1800s it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood
1981: First in vitro stem cell line developed from mice
1988: Embryonic stem cell lines created from a hamster
1995: First embryonic stem cell line derived from a primate
1997: Cloned lamb from stem cells
1997: Leukemia origin found as haematopoietic stem cell, indicating possible proof of cancer stem cells

Funding in USA:

No federal law forever did embargo stem cell research in the United States, but only placed restrictions on funding and use, under Congress's power to spend. By executive order on March 9, 2009, President Barack Obama removed certain restrictions on federal funding for research involving new lines of human embryonic stem cells. Prior to President Obama's executive order, federal funding was limited to non-embryonic stem cell research and embryonic stem cell research based upon embryonic stem cell lines in existence prior to August 9, 2001. In 2011, a United States District Court "threw out a lawsuit that challenged the use of federal funds for embryonic stem cell research”.

Members Associated with Stem Cell Research:

     Discussion on Development, Regeneration, and Stem Cell Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cell, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cell Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and “evo-devo” (Evolutionary developmental biology).

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Stem Cell Therapy Market, By Region, 2009 2018

$Million

 

 

Why to attend???

Stem Cell Research-2017 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference. 

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://stemcell.omicsgroup.com/sponsors.php

UAS Major Universities which deals with Stem Cell Research 

·  University of Washington/Hutchinson Cancer Center

·  Oregon Stem Cell Center

·  University of  California Davis

·  University of  California San Francisco

·  University of California Berkeley

·  Stanford University

·   Mayo Clinic

Major Stem Cell Organization Worldwide:

·  Norwegian Center for Stem Cell Research

·  France I-stem

·  Stem Cell & Regenerative Medicine Ctr, Beijing

·  Stem Cell Research Centre, Korea

·  NSW Stem Cell Network

·  Monash University of  Stem Cell Labs

·  Australian Stem Cell Centre

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

 Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Figure 2: Global Market

Companies working for Stem Cells:

Company

Location

Business Type

Cynata Therapeutics

Armadale, Australia

Stem Cell Manufacturing Technology

Mesoblast

Melbourne, Australia

Regenerative Medicine

Activartis

Vienna, Austria

Dendritic Cell-Based Cancer Immunotherapy

Aposcience

Vienna, Austria

Treatments composed of mixture of cytokines, growth factors and other active components

Cardio3 Biosciences

Mont-Saint-Guibert, Belgium

Stem Cell Differentiation

Orthocyte (BioTime)

Alameda, CA

Cellular Therapies

Capricor

Beverly Hills, CA

Stem Cell Heart Treatments

Life Stem Genetics

Beverly Hills, CA

Autologous stem cell therapy

International Stem Cell

Carlsbad, CA

Proprietary Stem Cell Induction

Targazyme

Carlsbad, CA

Cell Therapy

DaVinci Biosciences

Costa Mesa, CA

Cellular Therapies

Invitrx Therapeutics

Irvine, CA

Autologous Stem Cell Therapy, Therapeutic & Cosmetic

 

 

Stem Cell Software’s :

  1. Cryus : Cryus is developed specially for Cord Blood Banks, Donor Centers, Stem Cells Collection Centers, Biotech Laboratories and Tissue Banks.
  2. Label-InnThe: Which allows to record the donor or the patient personal data into the database and generates the Donation Identification Number (DIN) according to ICCBBA international standard ISBT128. It serves as labelling software for blood samples and Stem Cells products.

Products Manufactured By Industry Related to Stem Cell:

RoboSep™-16 is the latest RoboSep™ instrument ingenuous for performing fully-automated cell separation from a huge number of samples. Using EasySep™, the column-free immunomagnetic cell separation system, RoboSep™-16 isolates desired cells from a wide range of samples from different species, tissue sources or sizes using positive or negative selection. Through an intuitive user interface, the RoboSep™-16 simultaneously isolates cells from up to sixteen samples with minimal hands on time. By automating all reagent and sample handling steps, and through the use of disposable pipette tips, the RoboSep™-16 rapidly isolates all desired cells while minimizing the risk of sample cross-contamination. After completion of the cell isolation procedure, cells of interest are immediately available for any downstream application.

The EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit is designed to isolate highly purified CD25+ cells from single cell suspensions of splenocytes or other tissues by positive selection. Desired cells are labeled with antibodies and magnetic particles.  The cells are separated without columns using an EasySep™ magnet.  Unwanted cells are simply poured off, while desired cells remain in the tube.  Isolated cells are immediately ready for downstream applications such as flow cytometry, cell culture, or suppression assays.

Featured Research:

       Gene therapy gives assurance for severe combined immunodeficiency, Researchers have initiated that gene therapy using a improved delivery system, or vector, can restore the immune systems of children with X-linked severe combined immunodeficiency (SCID-X1), a rare, life-threatening inherited condition that primarily affects boys. Previous efforts to treat SCID-X1 with gene therapy were initially efficacious, but approximately one-quarter of the children developed leukemia two to five years after treatment. Results from a study partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that the new vector is equally effective at restoring immunity and may be safer than previous approaches.

References:

http://www.stemcell.com/en/Products/All-Products/EasySep-Mouse-CD25-Regulatory-T-Cell-Positive-Selection-Kit.aspx

  1. http://www.stemcell.com/en/Products/All-Products/EasySep-Mouse-CD25-Regulatory-T-Cell-Positive-Selection-Kit.aspx
  2. http://seekingalpha.com/article/1347281-investing-in-the-stem-cell-sector-an-overview
  3. http://mbbnet.umn.edu/scmap/scresearchmap.html
  4. http://biopharmguy.com/links/company-by-location-stem-cells.php
  5. http://www.marketwired.com/press-release/latest-research-shows-stem-cell-product-market-to-reach-6-billion-by-2016-1688406.htm

 

Past Conference Report

Stem Cell Congress 2016 Report
 
7th Annual Conference on Stem Cell and Regenerative Medicine was organized during August 04-05, 2016 at Manchester, UK. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.
 
This conference was based on the theme “Advanced Approaches In Stem Cell and Regenerative Medicine”  
 
The Organizing Committee would like to thank the moderator Dr. Nilanjana Maulik (University of Connecticut, USA) for her contribution which resulted in smooth functioning of the conference.
 
The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:
 
Barritault Denis - The importance of extra cellular matrix organization and the use of RGTA technology in regenerative Medicine(OTR3, France)
 
Y James Kang -Rejuvenation therapy for ischemic heart disease(Sichuan University, China)
 
Taihua Wang- Significant physical function improvements of 3 serious injured patients after neural stem cell therapy (Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd, China)
 
Gang Zhang- Using ‘Mouse Clone Model’ to open the door for human iPSC therapy (Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd, China)
 
Pedro Morouço - A novel regenerative medicine approach to reconstruct the temporomandibular joint disk (Centro Empresarial da Marinha Grande, Portugal)
 
Various sessions were chaired and co-chaired by: Barritault Denis-OTR3, France; Hazem Barmada- Mississippi Stem cell Treatment Center, USA;Serban San-Marina- Mayo Clinic, USA; Raphael Gorodetsky- Hadassah-Hebrew University Medical Center, Israel
 
ConferenceSeries LLC has taken the privilege of felicitating Stem Cell Congress -2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.
 
The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Stem Cell Congress-2016. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Stem Cell Research & Therapy: Open Access as a special issue.
 
We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, ConferenceSeries LLC would like to proudly announce the commencement of the " 9th Annual Conference on Stem Cell and Regenerative Medicine" to be organized during Sep 05-06, 2017 at Paris, France.
 
Mark your calendars for the upcoming Conference; we are hoping to see you soon at Stem Cell and Bio-Banking 2017, Osaka, Japan.
 
 
 

To Collaborate Scientific Professionals around the World

Conference Date October 23-24, 2017

Speaker Opportunity